SINO BIOPHARM ADR (SBHMY)
Institutional ownership reported to the SEC as of Q4 2024, across 14 quarters.
1
Reporting holders
$73.0K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | $73.0K | 8,855 | 0.00% | 7q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2024 | 1 | $73.0K | 8,855 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 1 | $85.0K | 8,855 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 1 | $60.6K | 8,855 | 0 | 0 | 0 | 0.0% |
| Q1 2024 | 1 | $68.3K | 8,855 | 0 | 0 | 0 | 0.0% |
| Q4 2023 | 1 | $78.7K | 8,855 | 0 | 0 | 0 | 0.0% |
| Q3 2023 | 1 | $64.0K | 8,855 | 0 | 0 | 0 | 0.0% |
| Q2 2023 | 1 | $77.1K | 8,855 | 1 | 0 | 0 | 0.0% |
| Q1 2023 | 1 | $1.7K | 151 | 1 | 0 | 0 | 0.0% |
| Q2 2020 | 1 | $230.0K | 6,094 | 1 | 0 | 0 | 0.0% |
| Q1 2020 | 1 | $569.0K | 21,581 | 1 | 0 | 0 | 0.0% |
| Q3 2019 | 1 | $560.0K | 22,023 | 0 | 1 | 0 | 0.0% |
| Q2 2019 | 1 | $342.0K | 16,734 | 0 | 0 | 0 | 0.0% |
| Q1 2019 | 1 | $305.0K | 16,734 | 0 | 0 | 0 | 0.0% |
| Q4 2018 | 1 | $221.0K | 16,734 | 0 | 0 | 0 | 0.0% |